Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Belgium
Summary - Conclusion Of A Framework Agreement With Several Attributors For The Supply Of Liposomal Doxorubicin (In Pegylated Form 2 Mg/Ml (20 Mg And 50 Mg Vials) For A Period Of Two Years, Renewable Twice For A Period Of One Year
Deadline - Feb 03, 2025
GT reference number - 101368715
Product classification - Pharmaceutical products
Address - Belgium
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 101368715
Document Type - Tender Notices
Description - Description: CONCLUSION OF A FRAMEWORK AGREEMENT WITH SEVERAL ATTRIBUTORS FOR THE SUPPLY OF LIPOSOMAL DOXORUBICIN (IN PEGYLATED FORM 2 MG/ML (20 MG AND 50 MG VIALS) FOR A PERIOD OF TWO YEARS, RENEWABLE TWICE FOR A PERIOD OF ONE YEARlocal title:: CONC LUSION D’UN ACCORD-CADRE AVEC PLUSIEURS ATTRIBUTAIRES EN VUE DE LA FOURNITURE DE DOXORUBICINE LIPOSOMALE (SOUS FORME PÉGYLÉE 2 MG/ML (FLACONS DE 20 MG ET DE 50 MG) POUR UNE DURÉE DE DEUX ANS RENOUVELABLE DEUX FOIS POUR UNE DURÉE D’UN ANContract Type: : Supplylocal description: : CONCLUSION D’UN ACCORD-CADRE AVEC PLUSIEURS ATTRIBUTAIRES EN VUE DE LA FOURNITURE DE DOXORUBICINE LIPOSOMALE (SOUS FORME PÉGYLÉE 2 MG/ML (FLACONS DE 20 MG ET
Gt Ref Id - 101368715
Deadline - Feb 03, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database